12/19/2024 4:30 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2024 4:15 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 4:04 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 4:06 PM | JOHNSTON EUGENE M (Reporting) Mangoceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2024 7:00 AM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 4:00 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/22/2024 7:00 AM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
10/21/2024 4:10 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2024 4:15 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2024 7:30 AM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2024 4:25 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2024 6:30 AM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2024 3:30 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
08/30/2024 4:25 PM | Mangoceuticals (Filer)
| Form AW | |
08/27/2024 6:45 PM | Cohen Jacob D. (Filed by) Mangoceuticals (Subject)
| Form SC 13D/A | |
08/27/2024 6:41 PM | Cohen Jacob D. (Reporting) Mangoceuticals (Issuer) Tiger Cub Trust (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 3:41 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2024 8:25 AM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 4:15 PM | Mangoceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024 7:00 AM | Mangoceuticals (Filer)
| Form POS AM | |
07/11/2024 7:15 AM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 3:40 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2024 5:25 PM | Hamilton Alex P. (Reporting) Mangoceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 9:20 AM | Hamilton Alex P. (Reporting) Mangoceuticals (Subject)
| Form 144/A | |
06/20/2024 5:11 PM | Hamilton Alex P. (Reporting) Mangoceuticals (Subject)
| Form 144/A | |
06/18/2024 1:57 PM | Hamilton Alex P. (Reporting) Mangoceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024 12:28 PM | Hamilton Alex P. (Reporting) Mangoceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 4:15 PM | D'Alessio Lorraine Pamela (Reporting) Mangoceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:15 PM | Cohen Jacob D. (Filed by) Mangoceuticals (Subject)
| Form SC 13D/A | |
06/05/2024 4:15 PM | Cohen Jacob D. (Reporting) Mangoceuticals (Issuer) Tiger Cub Trust (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:15 PM | Mangoceuticals (Issuer) MYERS KENNY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:15 PM | Hamilton Alex P. (Reporting) Mangoceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:15 PM | Hammer Amanda Elizabeth (Reporting) Mangoceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:15 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2024 12:59 PM | Mangoceuticals (Filer)
| Form ARS | |
05/16/2024 8:19 AM | Mangoceuticals (Filer)
| Form DEF 14A | |
05/15/2024 3:52 PM | Mangoceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 8:00 AM | Mangoceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/09/2024 11:15 PM | Mangoceuticals (Filer)
| Form EFFECT | |
05/06/2024 4:32 PM | Mangoceuticals (Filer)
| Form S-1/A | |
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
05/06/2024 3:43 PM | Mangoceuticals (Filer)
| Form PRE 14A | |
05/02/2024 7:00 AM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 7:30 AM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 4:28 PM | Mangoceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
04/11/2024 3:30 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 4:21 PM | Mangoceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 4:28 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 8:00 AM | Mangoceuticals (Filer)
| Form DEF 14A | |
02/20/2024 6:32 AM | Mangoceuticals (Filer)
| Form PRE 14A | |
01/25/2024 4:16 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/22/2024 6:42 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 8:51 PM | Mangoceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 8:51 PM | Cohen Jacob D. (Filed by) Mangoceuticals (Subject)
| Form SC 13D/A | |
12/29/2023 8:52 PM | Cohen Jacob D. (Reporting) Mangoceuticals (Issuer) Tiger Cub Trust (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |